STAAR Surgical Files Definitive Additional Materials

TL;DR

STAAR Surgical filed extra docs on 10/16/25, says 'no further action needed'.

AI Summary

STAAR Surgical Company (STAAR) filed a DEFA14A on October 16, 2025, indicating they are providing definitive additional materials. The filing includes a press release where STAAR Surgical affirms that no further action is required, suggesting a response to a previous inquiry or event. The company, incorporated in Delaware with its principal office in Monrovia, California, operates in the ophthalmic goods sector.

Why It Matters

This filing provides updated or supplementary information to shareholders, potentially related to corporate actions or responses to market events. Investors should review these materials for the latest company communications.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of additional materials and does not appear to contain significant new risks or negative information.

Key Players & Entities

• STAAR SURGICAL CO (company) — Registrant
• STAAR (company) — Abbreviation for STAAR Surgical Company
• 0000718937 (company) — Central Index Key
• 953797439 (company) — EIN
• DE (company) — State of Incorporation
• 1911 WALKER AVE (company) — Business Address Street 1
• MONROVIA (company) — Business Address City
• CA (company) — Business Address State
• 91016 (company) — Business Address ZIP
• 6263037902 (company) — Business Phone

FAQ

Filing Documents

• d15796ddefa14a.htm (DEFA14A) — 26KB
• 0001193125-25-241528.txt ( ) — 27KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock pr

View Full Filing

View this DEFA14A filing on SEC EDGAR